Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Aug-23 7:08 PM View:  | Kezar Life Sciences, Inc. (KZR) | 15-Aug-23 | Gift | 3,500,000 | -- | -- | (64%) 5.45M to 1.95M | |
| 17-Aug-23 5:34 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 15-Aug-23 | Gift | 2,000,000 | -- | -- | (29%) 7.0M to 5.0M | |
| 25-Jul-23 4:01 PM View: | Greenlight Biosciences Hold... (GRNA) | 24-Jul-23 | Disposition (other) | 16,919,200 | -- | -- | (100%) 16.92M to 0 | |
| 31-Mar-23 4:05 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 29-Mar-23 | Private Sale | 29,048 | $30.45 | $884,512.00 | (< 1%) 7.03M to 7.0M | |
| 29-Mar-23 4:05 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 28-Mar-23 | Sale | 100,000 | $30.37 | $3,037,000.00 | (1%) 7.13M to 7.03M | |
| 29-Mar-23 4:05 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 27-Mar-23 | Private Sale | 60,964 | $30.50 | $1,859,560.00 | (< 1%) 7.19M to 7.13M | |
| 23-Mar-23 4:05 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 21-Mar-23 | Private Sale | 63,448 | $31.91 | $2,024,490.00 | (< 1%) 7.25M to 7.19M | |
| 17-Mar-23 4:05 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 16-Mar-23 | Private Sale | 9,122 | $32.55 | $296,921.00 | (< 1%) 7.26M to 7.25M | |
| 16-Mar-23 10:00 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 15-Mar-23 | Sale | 150,000 | $33.27 | $4,991,000.00 | (2%) 7.41M to 7.26M | |
| 16-Mar-23 10:00 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 14-Mar-23 | Private Sale | 70,714 | $34.54 | $2,442,460.00 | (< 1%) 7.48M to 7.41M | |
| 06-Mar-23 9:10 AM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 02-Mar-23 | Private Sale | 50,000 | $33.75 | $1,687,500.00 | (< 1%) 7.53M to 7.48M | |
| 24-Feb-23 4:13 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 23-Feb-23 | Sale | 50,000 | $35.57 | $1,778,270.00 | (< 1%) 7.63M to 7.58M | |
| 24-Feb-23 4:13 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 22-Feb-23 | Private Sale | 50,000 | $36.00 | $1,799,840.00 | (< 1%) 7.68M to 7.63M | |
| 28-Feb-23 4:06 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 22-Feb-23 | Private Sale | 50,000 | $34.73 | $1,736,350.00 | (< 1%) 7.58M to 7.53M | |
| 07-Feb-23 4:11 PM View: | Kezar Life Sciences, Inc. (KZR) | 06-Feb-23 | Sale | 40,000 | $6.88 | $275,320.00 | (< 1%) 5.49M to 5.45M | |
| 07-Feb-23 4:11 PM View: | Kezar Life Sciences, Inc. (KZR) | 03-Feb-23 | Sale | 25,000 | $7.15 | $178,650.00 | (< 1%) 5.51M to 5.49M | |
| 03-Feb-23 4:32 PM View: | Kezar Life Sciences, Inc. (KZR) | 02-Feb-23 | Sale | 50,000 | $7.19 | $359,500.00 | (< 1%) 5.56M to 5.51M | |
| 03-Feb-23 4:32 PM View: | Kezar Life Sciences, Inc. (KZR) | 01-Feb-23 | Sale | 40,000 | $6.95 | $278,000.00 | (< 1%) 5.6M to 5.56M | |
| 01-Feb-23 4:07 PM View: | Kezar Life Sciences, Inc. (KZR) | 31-Jan-23 | Sale | 30,000 | $7.08 | $212,400.00 | (< 1%) 5.63M to 5.6M | |
| 01-Feb-23 4:07 PM View: | Kezar Life Sciences, Inc. (KZR) | 30-Jan-23 | Sale | 30,000 | $6.91 | $207,300.00 | (< 1%) 5.66M to 5.63M | |
| 27-Jan-23 4:17 PM View: | Kezar Life Sciences, Inc. (KZR) | 25-Jan-23 | Sale | 50,000 | $6.85 | $342,500.00 | (< 1%) 5.71M to 5.66M | |
| 25-Jan-23 6:17 PM View: | Kezar Life Sciences, Inc. (KZR) | 24-Jan-23 | Sale | 80,000 | $6.98 | $558,400.00 | (1%) 5.79M to 5.71M | |
| 25-Jan-23 6:17 PM View: | Kezar Life Sciences, Inc. (KZR) | 23-Jan-23 | Sale | 80,000 | $6.81 | $544,800.00 | (1%) 5.87M to 5.79M | |
| 19-Jan-23 4:12 PM View: | Kezar Life Sciences, Inc. (KZR) | 17-Jan-23 | Sale | 6,114 | $6.79 | $41,514.10 | (< 1%) 5.88M to 5.87M | |
| 17-Jan-23 4:28 PM View: | Kezar Life Sciences, Inc. (KZR) | 13-Jan-23 | Sale | 1,971 | $7.15 | $14,092.70 | (< 1%) 5.88M to 5.88M | |
| 17-Jan-23 4:28 PM View: | Kezar Life Sciences, Inc. (KZR) | 12-Jan-23 | Sale | 5,000 | $6.77 | $33,850.00 | (< 1%) 5.89M to 5.88M | |
| 09-Jan-23 4:08 PM View: | Kezar Life Sciences, Inc. (KZR) | 06-Jan-23 | Sale | 3,000 | $6.89 | $20,670.00 | (< 1%) 5.89M to 5.89M | |
| 09-Jan-23 4:08 PM View: | Kezar Life Sciences, Inc. (KZR) | 05-Jan-23 | Sale | 12,162 | $6.97 | $84,769.10 | (< 1%) 5.9M to 5.89M | |
| 05-Jan-23 4:10 PM View: | Kezar Life Sciences, Inc. (KZR) | 04-Jan-23 | Sale | 30,000 | $7.17 | $215,100.00 | (< 1%) 5.93M to 5.9M | |
| 05-Jan-23 4:10 PM View: | Kezar Life Sciences, Inc. (KZR) | 03-Jan-23 | Sale | 500 | $7.10 | $3,550.00 | (< 1%) 5.93M to 5.93M | |
| 05-Jan-23 4:10 PM View: | Kezar Life Sciences, Inc. (KZR) | 29-Dec-22 | Sale | 25,000 | $7.10 | $177,500.00 | (< 1%) 5.96M to 5.93M | |
| 11-Jan-23 10:00 PM View: | Kezar Life Sciences, Inc. (KZR) | 18-Oct-22 | Gift | 120,000 | -- | -- | (2%) 6.05M to 5.93M | |
| 05-Oct-22 4:05 PM View: | Kezar Life Sciences, Inc. (KZR) | 04-Oct-22 | Sale | 3,612 | $8.82 | $31,857.50 | (< 1%) 6.08M to 6.08M | |
| 05-Oct-22 4:05 PM View: | Kezar Life Sciences, Inc. (KZR) | 03-Oct-22 | Sale | 28,700 | $8.78 | $251,957.00 | (< 1%) 6.11M to 6.08M | |
| 11-Jan-23 10:00 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 23-Sep-22 | Gift | 833,333 | -- | -- | (10%) 8.51M to 7.68M | |
| 11-Jan-23 10:00 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 20-Sep-22 | Gift | 33,333 | -- | -- | (< 1%) 8.55M to 8.51M | |
| 11-Jan-23 10:00 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 12-Sep-22 | Gift | 510,000 | -- | -- | (6%) 9.06M to 8.55M | |
| 15-Aug-22 6:48 PM View: | Greenlight Biosciences Hold... (GRNA) | 11-Aug-22 | Purchase | 3,061,220 | $3.92 | $12,000,000.00 | 22% 13.86M to 16.92M | |
| 04-Feb-22 5:15 PM View: | Greenlight Biosciences Hold... (GRNA) | 02-Feb-22 | Conversion | 12,858,200 | -- | -- | 100% 12.86M to 25.72M | |
| 04-Feb-22 5:15 PM View: | Greenlight Biosciences Hold... (GRNA) | 02-Feb-22 | Purchase | 1,000,000 | -- | -- | 4% 25.72M to 26.72M | |
| 25-Jan-22 4:46 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 11-Jan-22 | Conversion | 10,415,600 | -- | -- | 100% 10.42M to 20.83M | |
| 25-Jan-22 4:46 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 11-Jan-22 | Purchase | 263,158 | $19.00 | $5,000,000.00 | 1% 20.83M to 21.09M | |
| 18-Nov-21 4:16 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 18-Nov-21 | Market Purchase | 250,000 | $40.00 | $10,000,000.00 | 2% 12.56M to 12.81M | |
| 06-Feb-20 4:11 PM View: | Kezar Life Sciences, Inc. (KZR) | 04-Feb-20 | Private Purchase | 3,800,000 | $2.60 | $9,880,000.00 | 165% 2.31M to 6.11M | |
| 21-Jan-20 5:47 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 13-Jan-20 | Market Purchase | 540,540 | $37.00 | $20,000,000.00 | 4% 12.02M to 12.56M | 54% |
| 13-Mar-19 3:32 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 11-Mar-19 | Private Purchase | 441,176 | $17.00 | $7,499,990.00 | 4% 11.57M to 12.02M | |
| 24-Sep-18 6:05 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Sep-18 | Purchase | 40,000 | $19.84 | $793,600.00 | < 1% 11.53M to 11.57M | |
| 24-Sep-18 6:05 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Sep-18 | Purchase | 41,323 | $19.13 | $790,363.00 | < 1% 11.49M to 11.53M | |
| 19-Sep-18 7:42 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 19-Sep-18 | Purchase | 60,000 | $18.09 | $1,085,400.00 | < 1% 11.43M to 11.49M | |
| 19-Sep-18 7:42 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 18-Sep-18 | Purchase | 40,000 | $18.47 | $738,800.00 | < 1% 11.39M to 11.43M |